Equities

LifeTech Scientific Corp

LifeTech Scientific Corp

Actions
Health CareMedical Equipment and Services
  • Price (HKD)1.58
  • Today's Change0.02 / 1.28%
  • Shares traded5.43m
  • 1 Year change-33.33%
  • Beta0.9307
Data delayed at least 15 minutes, as of Jun 13 2024 09:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

LifeTech Scientific Corporation is an investment holding company principally engaged in the manufacturing and marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.

  • Revenue in HKD (TTM)1.37bn
  • Net income in HKD283.77m
  • Incorporated2006
  • Employees1.45k
  • Location
    LifeTech Scientific CorpCybio Electronic BuildingLangshn 2nd St,North Ar of Hgh-tch PrkNanshan DistrictSHENZHEN 518063ChinaCHN
  • Phone+86 75 586026250
  • Websitehttp://www.lifetechmed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zylox-Tonbridge Medical Technolgy Co Ltd568.90m-84.87m3.76bn765.00--1.11--6.60-0.2583-0.25831.7310.140.15920.9991480.65743,665.20-2.38---2.56--72.95---14.92--4.88--0.018--57.97--30.66------
OrbusNeich Medical Group Holdings Ltd1.20bn352.14m3.76bn1.25k10.741.319.763.130.42290.42291.443.480.40431.344.38962,438.5011.84--12.86--69.22--29.29--8.60--0.0198--12.45--143.76------
Modern Dental Group Ltd3.17bn404.10m4.18bn7.04k10.391.597.641.320.42450.42453.332.780.84689.105.49450,895.3010.747.0512.608.3453.6150.7712.689.242.5313.170.243839.9812.086.5083.3036.462.42--
Shanghai INT Medical Instruments Co Ltd811.54m168.66m4.83bn1.57k27.922.6322.325.950.98330.98334.7310.450.39042.227.75517,891.507.958.639.499.7658.1959.4420.3526.161.88--0.053531.8028.5029.9618.7921.7645.75--
Shanghai Conant Optical Co Ltd1.90bn352.52m4.86bn2.51k13.803.2311.722.560.82640.82644.453.520.93282.166.48756,015.6017.3412.5722.4018.6937.4035.2718.5814.642.15--0.133518.5712.7015.5631.5633.0413.49--
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd351.31m163.35m5.62bn219.0034.432.7131.3216.010.47110.47111.015.990.17170.584810.301,604,140.007.98--8.25--88.62--46.50--22.93--0.0013--31.58--864.81------
AK Medical Holdings Ltd1.18bn196.30m5.69bn1.05k28.912.2119.334.820.17530.17531.052.300.37870.84062.381,120,867.006.309.277.5211.2861.6665.0616.6521.782.77--0.043122.653.9712.74-11.074.6721.675.88
Kangji Medical Holdings Ltd998.23m543.32m7.12bn1.00k12.651.8113.617.130.46330.46330.85123.230.22451.764.76995,240.9010.9714.4012.4516.1880.0481.7548.8457.2417.16--0.01149.5817.7621.235.2828.0041.50--
LifeTech Scientific Corp1.37bn283.77m7.27bn1.45k24.802.0038.315.320.06330.06330.30720.78460.30220.749110.46944,660.302.567.093.058.5178.5779.668.4822.692.27--0.14590.0015.4817.88-19.0916.8026.11--
Angelalign Technology Inc1.59bn57.64m10.20bn2.88k176.382.8370.656.410.34160.34169.4321.290.31945.3316.70551,871.801.055.761.297.5962.3864.333.3013.984.12--0.0188--16.2424.75-74.99-2.2020.54--
MicroPort Scientific Corp7.43bn-3.73bn10.73bn8.23k--1.81--1.45-2.04-2.044.073.230.23991.095.32902,507.20-16.38-11.85-27.68-18.0455.9762.96-68.28-44.431.26-4.210.5477--13.077.27-9.42--19.44--
Data as of Jun 13 2024. Currency figures normalised to LifeTech Scientific Corp's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

15.20%Per cent of shares held by top holders
HolderShares% Held
HHLR Advisors Ltd.as of 30 Jun 2023414.14m8.94%
The Vanguard Group, Inc.as of 09 May 202485.72m1.85%
BlackRock Fund Advisorsas of 09 May 202445.33m0.98%
Dimensional Fund Advisors LPas of 09 May 202443.23m0.93%
Wellington Management Co. LLPas of 31 Mar 202439.24m0.85%
Bosera Asset Management Co., Ltd.as of 31 Dec 202230.68m0.66%
Norges Bank Investment Managementas of 31 Dec 202313.49m0.29%
BlackRock Advisors (UK) Ltd.as of 09 May 202413.03m0.28%
APG Asset Management NVas of 31 Dec 20229.69m0.21%
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 20239.40m0.20%
More ▼
Data from 31 Dec 2023 - 06 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.